JRSIS Health Care Statistics
Total Valuation
JRSS has a market cap or net worth of 1.90 million. The enterprise value is 3.21 million.
| Market Cap | 1.90M |
| Enterprise Value | 3.21M |
Important Dates
The last earnings date was Friday, March 28, 2025.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
JRSS has 84.60 million shares outstanding. The number of shares has decreased by -28.30% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 84.60M |
| Shares Change (YoY) | -28.30% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 96.30% |
| Owned by Institutions (%) | n/a |
| Float | 3.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.55 |
| PB Ratio | -8.12 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.55 |
| EV / Sales | 0.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.38 |
Financial Position
The company has a current ratio of 0.78
| Current Ratio | 0.78 |
| Quick Ratio | 0.59 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.84 |
| Interest Coverage | -12.81 |
Financial Efficiency
Return on equity (ROE) is -478.87% and return on invested capital (ROIC) is -53.17%.
| Return on Equity (ROE) | -478.87% |
| Return on Assets (ROA) | -32.02% |
| Return on Invested Capital (ROIC) | -53.17% |
| Return on Capital Employed (ROCE) | 296.13% |
| Revenue Per Employee | 96,414 |
| Profits Per Employee | -13,611 |
| Employee Count | 36 |
| Asset Turnover | 2.63 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.47% in the last 52 weeks. The beta is 0.26, so JRSS's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -97.47% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | 0.24 |
| Relative Strength Index (RSI) | 44.23 |
| Average Volume (20 Days) | 10,686 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, JRSS had revenue of 3.47 million and -489,980 in losses. Loss per share was -0.01.
| Revenue | 3.47M |
| Gross Profit | 442,158 |
| Operating Income | -675,664 |
| Pretax Income | -569,020 |
| Net Income | -489,980 |
| EBITDA | -626,775 |
| EBIT | -675,664 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 1,372 in cash and 1.34 million in debt, giving a net cash position of -1.34 million or -0.02 per share.
| Cash & Cash Equivalents | 1,372 |
| Total Debt | 1.34M |
| Net Cash | -1.34M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | -234,477 |
| Book Value Per Share | -0.00 |
| Working Capital | -512,474 |
Cash Flow
In the last 12 months, operating cash flow was -730,303 and capital expenditures -1,235, giving a free cash flow of -731,538.
| Operating Cash Flow | -730,303 |
| Capital Expenditures | -1,235 |
| Free Cash Flow | -731,538 |
| FCF Per Share | -0.01 |
Margins
Gross margin is 12.74%, with operating and profit margins of -19.47% and -14.12%.
| Gross Margin | 12.74% |
| Operating Margin | -19.47% |
| Pretax Margin | -16.39% |
| Profit Margin | -14.12% |
| EBITDA Margin | -18.06% |
| EBIT Margin | -19.47% |
| FCF Margin | n/a |
Dividends & Yields
JRSS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 28.30% |
| Shareholder Yield | 28.30% |
| Earnings Yield | -25.74% |
| FCF Yield | -38.43% |
Stock Splits
The last stock split was on June 30, 2023. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jun 30, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
JRSS has an Altman Z-Score of 2.47. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.47 |
| Piotroski F-Score | n/a |